Skip to main content

Advertisement

Table 1 BMFS patient characteristics

From: 18F-FLT PET/MRI for bone marrow failure syndrome-initial experience

Patient Age Sex Diagnosis WBC Hb Plt Bone marrow FLT-SUV DWI Progress
(× 103/μL) (g/dL) (×103/μL) biopsy Ilium Lumbar Sternum Score
1 88 M Non-severe AA 5 7.1 113 Hypocellular 3.7 8.9 6.5 1  
2 63 F Non-severe AA 2.4 12 64 Hypocellular 1.6 7.8 8.2 1  
3 81 M Non-severe AA 1.9 5.1 117 Hypocellular 0.4 4.9 1.2 1  
4 24 F Non-severe AA 2 11 12 Hypocellular 0.2 14.2 13.7 1  
5 79 M Non-severe AA 2.7 10.3 35 Hypocellular 1 7.8 14.7 2  
6 66 F Severe AA 1 5.2 25 Hypocellular 0.9 4.1 3.9 1  
7 67 M Severe AA 3.1 5.6 4 Hypocellular 0.3 0.5 3.2 1  
8 70 M MDS 1.3 5.8 34 Normocellular 7.9 11.4 13.9 1  
9 66 M MDS 1.6 8.4 47 Normocellular 7.8 12.1 10.1 1  
10 80 M MDS 3 6.8 105 Hypercellular 8.6 11.5 9.2 2 AML
11 68 F MDS 7 6 13 Hypercellular 9.4 9.5 9.7 1 AML
12 68 M MDS 1 7.2 26 Normocellular 5.1 5.3 7.1 1 AML
13 66 M MDS 8.6 11.1 112 Normocellular 5 6.4 6.5 2  
14 65 F MDS 2.5 7.1 37 Hypercellular 11.5 13 16.5 1  
15 81 F MDS 6.3 10 74 Hypercellular 7.4 9.9 9.8 3  
16 18 M hypo-MDS 0.8 7.5 121 Hypocellular 2.9 9.7 8.3 1  
17 77 M hypo-MDS 1.7 8.3 20 Hypocellular 2.1 7.8 1.3 1 AML
18 68 M hypo-MDS 3 10 133 Hypocellular 1.2 3 6.2 2  
19 72 M hypo-MDS 1.5 9.9 5 Hypocellular 1 3.3 4.6 2  
20 60 M hypo-MDS 1.3 8.3 154 Hypocellular 3.1 3.5 4.7 1 AML
21 75 M hypo-MDS 2.5 12 36 Hypocellular 1.6 2.8 8.8 1  
22 81 M hypo-MDS 2.5 8.3 39 Hypocellular 1.7 5.6 3.5 2 AML
23 90 M hypo-MDS 2.7 7.9 319 Normocellular 3.1 6.1 7.5 2  
24 69 M MPN (primary MF) 7 11.6 14 Normocellular 2.7 4.7 4 3  
25 70 M MPN (secondary MF) 19.5 11.2 438 Hypercellular 9.5 16 15.1 3  
  1. M male, F female, AA aplastic anemia, MPN myeloproliferative neoplasms, MF myelofibrosis, MDS myelodysplastic syndrome, AML acute myeloid leukemia, WBC white blood cell, Hb hemoglobin, and Plt platelet count